Aristotle University Of Thessaloniki (AUTH)
Σύγκριση μικροβιώματος του γαστρεντερικού συστήματος μεταξύ ασθενών με λοίμωξη από Clostridioides difficile και υγιών ατόμων
Abstract
dc:descriptionClostridioides difficile (C. difficile) is one of the most significant hospital-acquired pathogens, and the infection it causes is associated with disturbances in the gut microbiome. C. difficile is transmitted via the fecal-oral route. Exposure to antibiotics is the primary risk factor for the development of Clostridioides difficile infection (CDI), as it disrupts the normal composition and function of the gut microbiome. The development of CDI is facilitated by disturbances in the gut microbiome, while restoring the diversity and abundance of beneficial bacteria in the gut microbiome prevents its development. This study aims to map the gut microbiome in both healthy individuals and patients with CDI. The results will be analyzed and compared by gender. In addition, the core gut microbiome of the two study groups will be compared to identify any changes in the gut microbiome in individuals with confirmed CDI. The study included 48 participants, residents of Northern Greece aged 18 and older. The participants were divided into two groups: 16 healthy individuals and 32 patients with CDI, that is, hospitalized patients with diarrhea who tested positive for C. difficile toxin. Fecal samples from the patients were collected after the onset of diarrhea. CDI was diagnosed using rapid detection of toxin-producing C. difficile and confirmed using a combination of immunoenzymatic, culture, and molecular methods. The microbiome was analyzed by sequencing the hypervariable regions of the 16S rRNA (16S ribosomal RNA) gene on an Ion GeneStudio™ S5 system. For each sample, two sets of primers were used—V2-4-8 and V3-6, 7-9—which allow for the precise identification and characterization of a broad spectrum of bacteria at the genus and species levels. Further statistical analysis of the microbiome data was performed using the open-source programming language R, version 3.5.2. Among patients with CDI, the most abundant phyla were Firmicutes and Proteobacteria, while Enterobacteriaceae and Enterococcaceae were the most abundant families. Analysis at the genus level showed that the genus Enterococcus was the dominant genus in the group of patients with CDI, in contrast to healthy individuals, in whom Faecalibacterium was the dominant genus. Further analysis using the MaAsLin2 (Microbiome Multivariable Association with Linear Models) tool showed that the Enterococcaceae family and the Enterococcus genus were relatively more abundant in patients with CDI compared to healthy individuals, confirming the findings of the abundance analysis. Analysis of α-diversity and β-diversity revealed no differences between patients with CDI and healthy individuals. An assessment of abundance and diversity between the two biological sexes within the patient group showed no differences.In conclusion, the microbiome analysis of the two study groups showed differences in the gut microbiome between healthy individuals and patients with CDI. However, further studies involving a larger number of participants are needed to investigate the potential role of the gut microbiome as a prognostic biomarker for the onset of CDI.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mougiou, Dimitra
- Μούγιου, Δήμητρα
Subjects
dc:subject × 14- Εντερικό μικροβίωμα
- Λοίμωξη από Clostridioides difficile
- Βακτηριακή ποικιλομορφία
- Μικροβιακή αφθονία
- Gut microbiome
- Clostridioides difficile infection
- Bacterial diversity
- Microbial abundance
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μικροβιολογία (ιατρική)
- Clinical Medicine
- Medical and Health Sciences
- Microbiology (medical)
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62354